Cited by 318DNA Repair MechanismsCancer-related Molecular PathwaysMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 70 of the 72 references it cites were found in a registry or an index.

Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase

Open access

Buisson, Rémi, Boisvert, Jessica L., Benes, Cyril H., Zou, Lee·2015·Molecular Cell

DOI 10.1016/j.molcel.2015.07.029PMC PMC4575890

Open this paper in CoChat — free account Open PDF

Abstract

The ATR-Chk1 pathway is critical for DNA damage responses and cell-cycle progression. Chk1 inhibition is more deleterious to cycling cells than ATR inhibition, raising questions about ATR and Chk1 functions in the absence of extrinsic replication stress. Here we show that a key role of ATR in S phase is to coordinate RRM2 accumulation and origin firing. ATR inhibitor (ATRi) induces massive ssDNA accumulation and replication catastrophe in a fraction of early S-phase cells. In other S-phase cells, however, ATRi induces moderate ssDNA and triggers a DNA-PK and Chk1-mediated backup pathway to suppress origin firing. The backup pathway creates a threshold such that ATRi selectively kills cells under high replication stress, whereas Chk1 inhibitor induces cell death at a lower threshold. The levels of ATRi-induced ssDNA correlate with ATRi sensitivity in a panel of cell lines, suggesting that ATRi-induced ssDNA could be predictive of ATRi sensitivity in cancer cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2015.07.029

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
Self-citation
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Causes and consequences of replication stress
Zeman, M. K., & Cimprich, K. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2897 · Cited by 2,079
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
ATR: an essential regulator of genome integrity
Cimprich, K. A., & Cortez, D. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2450 · Cited by 1,798
Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625

Flagged first, then by citations

Show all 72 references

2 of the 72 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 318

Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer
Guo, Y., Wang, J., Benedict, B., Yang, C. G., van Gemert, F. P. A., Ma, X., Gao, D., Wang, H., Zhang, S., Lieftink, C., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00981-0 · Cited by 45
Replication stress response in cancer stem cells as a target for chemotherapy
Manic, G., Sistigu, A., Corradi, F., Musella, M., Maria, R. D., & Vitale, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.003 · Cited by 42
XRCC2 Regulates Replication Fork Progression during dNTP Alterations
Saxena, S., Somyajit, K., & Nagaraju, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.085 · Cited by 43
Lamin A/C recruits ssDNA protective proteins RPA and RAD51 to stalled replication forks to maintain fork stability
Graziano, S., Coll-Bonfill, N., Teodoro-Castro, B., Kuppa, S., Jackson, J., Shashkova, E. V., Mahajan, U., Vindigni, A., Antony, E., & Gonzalo, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101301 · Cited by 45
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade
Ngoi, N. Y. L., Peng, G., & Yap, T. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-025136 · Cited by 42
ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion
Menolfi, D., Lee, B. J., Zhang, H., Jiang, W., Bowen, N. E., Wang, Y., Zhao, J., Holmes, A. B., Gershik, S., Rabadán, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39332-5 · Cited by 41
Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage
Fernandez, A., Artola, M., Leon, S., Otegui, N., Jimeno, A., Serrano, D., & Calvo, A. (2025) · Cells · doi:10.3390/cells14100748 · Cited by 46
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers
Hocke, S., Guo, Y., Job, A., Orth, M., Ziesch, A., Lauber, K., Toni, E. N. D., Gress, T. M., Herbst, A., Göke, B., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6857 · Cited by 40
Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine
Koh, S., Wallez, Y., Dunlop, C. R., Fernández, S. B. D. Q., Bapiro, T. E., Richards, F. M., & Jodrell, D. I. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3932 · Cited by 40
Genome-Wide Screens Reveal that Resveratrol Induces Replicative Stress in Human Cells
Benslimane, Y., Bertomeu, T., Coulombe‐Huntington, J., McQuaid, M. E., Sánchez‐Osuna, M., Papadopoli, D. J., Avizonis, D. Z., Russo, M. D. S. T., Huard, C., Topisirović, I., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.010 · Cited by 38
ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus
Manolakou, T., Nikolopoulos, D., Gkikas, D., Filia, A., Samiotaki, M. K., Stamatakis, G. M., Fanouriakis, A., Politis, P. K., Banos, A., Alissafi, T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo5840 · Cited by 39
Cyclers’ kinases in cell division: from molecules to cancer therapy
Milletti, G., Colicchia, V., & Cecconi, F. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01196-z · Cited by 39
Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine
Goss, K. L., Koppenhafer, S. L., Harmoney, K. M., Terry, W. W., & Gordon, D. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18776 · Cited by 40
Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
Mortensen, A. C. L., Mohajershojai, T., Hariri, M., Pettersson, M., & Spiegelberg, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.532285 · Cited by 39
DNA replication stress and emerging prospects for PARG inhibitors in ovarian cancer therapy
Pillay, N., Brady, R. M., Dey, M., Morgan, R. D., & Taylor, S. S. (2021) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2021.01.004 · Cited by 37
Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
Hafez, A. Y., Messinger, J. E., McFadden, K., Fenyőfalvi, G., Shepard, C., Lenzi, G. M., Kim, B., & Luftig, M. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.46 · Cited by 36
Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
Qi, W., Xu, X., Wang, M., Li, X., Wang, C., Sun, L., Zhao, D., & Sun, L. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.022 · Cited by 37
Targeting DNA Repair in Ovarian Cancer Treatment Resistance
Wong‐Brown, M. W., van der Westhuizen, A., & Bowden, N. A. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.03.005 · Cited by 36
Mus81-Eme1–dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrity
Calzetta, N. L., Besteiro, M. A. G., & Gottifredi, V. (2020) · Science Advances · doi:10.1126/sciadv.abc8257 · Cited by 35
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress
Igarashi, T., Mazevet, M., Yasuhara, T., Yano, K., Mochizuki, A., Nishino, M., Yoshida, T., Yoshida, Y., Takamatsu, N., Yoshimi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40578-2 · Cited by 38
Self-citation
The S-phase-induced lncRNA SUNO1 promotes cell proliferation by controlling YAP1/Hippo signaling pathway
Hao, Q., Zong, X., Sun, Q., Lin, Y.-C., Song, Y. J., Hashemikhabir, S., Hsu, R. Y. C., Kamran, M. Z., Chaudhary, R., Tripathi, V., et al. (2020) · eLife · doi:10.7554/elife.55102 · Cited by 35
CENP-E as a target for cancer therapy: Where are we now?
El‐Arabey, A. A., Salama, S. A., & Abd‐Allah, A. R. A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.037 · Cited by 34
Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells
Chopra, S. S., Jenney, A., Palmer, A. C., Niepel, M., Chung, M., Mills, C. E., Sivakumaren, S. C., Liu, Q., Chen, J.-Y., Yapp, C., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.11.001 · Cited by 33
Replication stress response defects are associated with response to immune checkpoint blockade in nonhypermutated cancers
McGrail, D. J., Pilie, P. G., Dai, H., Lam, T., Liang, Y., Voorwerk, L., Kok, M., Zhang, X. H.-F., Rosen, J. M., Heimberger, A. B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe6201 · Cited by 36
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
Nam, A., Jin, M. H., Park, J. E., Bang, J., Oh, D., & Bang, Y. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2018.526 · Cited by 33
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas
Restelli, V., Lupi, M., Chilà, R., Vagni, M., Tarantelli, C., Spriano, F., Gaudio, E., Bertoni, F., Damia, G. L. M., & Carrassa, L. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0919 · Cited by 35
Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
Roger, É., Gout, J., Arnold, F., Beutel, A. K., Müller, M., Abaei, A., Barth, T. F. E., Rasche, V., Seufferlein, T. T. W., Perkhofer, L., et al. (2020) · Cells · doi:10.3390/cells9092110 · Cited by 31
Understanding the interplay between dNTP metabolism and genome stability in cancer
Yagüe-Capilla, M., & Rudd, S. G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050775 · Cited by 31
Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe
Warren, N. J. H., & Eastman, A. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005231 · Cited by 30
Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition
Shu, Z., Li, Z., Huang, H., Chen, Y., Fan, J., Yu, L., Wu, Z., Tian, L., Qi, Q., Peng, S., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01403-y · Cited by 31
Exploiting Replication Stress as a Novel Therapeutic Intervention
Martin, J. C., Hoegel, T. J., Lynch, M. L., Woloszynska‐Read, A., Melendy, T., & Ohm, J. E. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0651 · Cited by 32
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach
Johnson, T. I., Minteer, C. J., Kottmann, D., Dunlop, C. R., Fernández, S. B. D. Q., Carnevalli, L. S., Wallez, Y., Lau, A., Richards, F. M., & Jodrell, D. I. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103396 · Cited by 30
Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer
Flynn, M. J., & Ledermann, J. A. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.13 · Cited by 31
Targeting DNA damage response pathways to activate the STING innate immune signaling pathway in human cancer cells
Wayne, J., Brooks, T., Landras, A., & Massey, A. J. (2021) · FEBS Journal · doi:10.1111/febs.15747 · Cited by 29
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
García, H. D., Pusch, F. F., Bei, Y., von Stebut, J., Ibáñez, G., Guillan, K. C., Imami, K., Gürgen, D., Rolff, J., Helmsauer, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32023-7 · Cited by 29
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer
Brunner, A., Rahmanto, A. S., Johansson, H. J., Franco, M., Viiliäinen, J., Gazi, M., Frings, O., Fredlund, E., Spruck, C., Lehtiö, J., et al. (2020) · eLife · doi:10.7554/elife.57894 · Cited by 29
Inhibition of ATR potentiates the cytotoxic effect of gemcitabine on pancreatic cancer cells through enhancement of DNA damage and abrogation of ribonucleotide reductase induction by gemcitabine
Liu, S., Ge, Y., Wang, T., Edwards, H. J., Ren, Q., Jiang, Y., Quan, C., & Wang, G. (2017) · Oncology Reports · doi:10.3892/or.2017.5580 · Cited by 30
The downregulation of the RNA-binding protein Staufen2 in response to DNA damage promotes apoptosis
Zhang, X., Trépanier, V., Beaujois, R., Viranaïcken, W., Drobetsky, E. A., & DesGroseillers, L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw057 · Cited by 27
Chk1 loss creates replication barriers that compromise cell survival independently of excess origin firing
Besteiro, M. A. G., Calzetta, N. L., Loureiro, S. M., Habif, M., Betous, R., Pillaire, M., Maffia, A., Sabbioneda, S., Hoffmann, J., & Gottifredi, V. (2019) · The EMBO Journal · doi:10.15252/embj.2018101284 · Cited by 28
The Challenge of Combining Chemo- and Radiotherapy with Checkpoint Kinase Inhibitors
van Bijsterveldt, L., Durley, S. C., Maughan, T., & Humphrey, T. C. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3358 · Cited by 27
DNA-PK Deficiency in Alzheimer's Disease
Kanungo, J. (2016) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2016/3.1016 · Cited by 28
Interplay between the DNA damage response and the life cycle of DNA tumor viruses
Studstill, C. J., Mac, M., & Moody, C. A. (2023) · Tumour Virus Research · doi:10.1016/j.tvr.2023.200272 · Cited by 28
DDK Has a Primary Role in Processing Stalled Replication Forks to Initiate Downstream Checkpoint Signaling
Sasi, N. K., Coquel, F., Lin, Y., MacKeigan, J. P., Pasero, P., & Weinreich, M. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.001 · Cited by 25
The Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork
Saldanha, J., Rageul, J., Patel, J. A., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310488 · Cited by 28
Comparison of the different mechanisms of cytotoxicity induced by checkpoint kinase I inhibitors when used as single agents or in combination with DNA damage
Warren, N. J. H., & Eastman, A. R. (2019) · Oncogene · doi:10.1038/s41388-019-1079-9 · Cited by 27
ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways
Fedak, E. A., Adler, F. R., Abegglen, L. M., & Schiffman, J. D. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00868-6 · Cited by 29
The Role of Human Centromeric RNA in Chromosome Stability
Leclerc, S., & Kitagawa, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.642732 · Cited by 25
Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome
Lebrec, V., Poteau, M., Morretton, J., & Gavet, O. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.02.013 · Cited by 25
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia
Yu, H., Wu, S., Liu, S., Li, X., Gai, Y., Lin, H., Wang, Y., Edwards, H. J., Ge, Y., & Wang, G. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17274 · Cited by 25
Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral Replication
Kucharski, T. J., Ng, T. F., Sharon, D. M., Navid-Azarbaijani, P., Tavassoli, M., & Teodoro, J. G. (2016) · Journal of Virology · doi:10.1128/jvi.00936-16 · Cited by 25
The Role of the Transcriptional Response to DNA Replication Stress
Herlihy, A. E., & de Bruin, R. A. M. (2017) · Genes · doi:10.3390/genes8030092 · Cited by 26
Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine
Oo, Z. Y., Proctor, M. A., Stevenson, A. J., Nazareth, D., Fernando, M., Daignault, S. M., Lanagan, C. M., Walpole, S., Bonazzi, V., Škalamera, D., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12497 · Cited by 25
Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1
Corrales-Guerrero, S., Cui, T., Castro-Aceituno, V., Yang, L., Nair, S., Feng, H., Venere, M., Yoon, S. M., DeWees, T. A., Shen, C., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216308 · Cited by 24
Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes
Mavroeidi, D., Georganta, A., Panagiotou, Ε., Syrigos, K., & Souliotis, V. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052767 · Cited by 26
Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors In Vivo
Oo, Z. Y., Stevenson, A. J., Proctor, M. A., Daignault, S. M., Walpole, S., Lanagan, C. M., Chen, J., Škalamera, D., Spoerri, L., Ainger, S. A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2701 · Cited by 24
Everything in Moderation: Lessons Learned by Exploiting Moderate Replication Stress in Cancer
Nazareth, D., Jones, M. V., & Gabrielli, B. G. (2019) · Cancers · doi:10.3390/cancers11091320 · Cited by 24
Xeroderma Pigmentosa Group A (XPA), Nucleotide Excision Repair and Regulation by ATR in Response to Ultraviolet Irradiation
Musich, P. R., Li, Z., & Zou, Y. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-56017-5_4 · Cited by 23
Mechanism of DNA replication fork breakage and PARP1 hyperactivation during replication catastrophe
Ortega, P., Bournique, E., Li, J., Sanchez, A., Santiago, G., Harris, B. R., Striepen, J., Maciejowski, J., Green, A. M., & Buisson, R. (2025) · Science Advances · doi:10.1126/sciadv.adu0437 · Cited by 22
Self-citation
KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
Gaillard, S., Charasson, V., Ribeyre, C., Salifou, K., Pillaire, M., Hoffmann, J., Constantinou, A., Trouche, D., & Vandromme, M. (2021) · Biology Open · doi:10.1242/bio.057729 · Cited by 23
Targeting the DNA damage response beyond poly(ADP-ribose) polymerase inhibitors: novel agents and rational combinations
Ngoi, N. Y. L., Westin, S. N., & Yap, T. A. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000867 · Cited by 23
For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus
Studstill, C. J., & Moody, C. A. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-103452 · Cited by 24
Cellular Depletion of BRD8 Causes p53-Dependent Apoptosis and Induces a DNA Damage Response in Non-Stressed Cells
Lashgari, A., Fauteux, M., Maréchal, A., & Gaudreau, L. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-32323-3 · Cited by 26
The clinical significance of CHEK1 in breast cancer: a high-throughput data analysis and immunohistochemical study.
Wu, M., Pang, J., Sun, Q., Huang, Y., Hou, J., Chen, G., Zeng, J., & Feng, Z. (2019) · Europe PMC (PubMed Central) · Cited by 22
Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy
Massey, A. J. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.024 · Cited by 23
The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity
Prasad, C. B., Oo, A., Liu, Y., Qiu, Z., Zhong, Y., Li, N., Singh, D., Xin, X., Cho, Y.-J., Li, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48076-9 · Cited by 24
Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
Segeren, H. A., van Liere, E. A., Riemers, F. M., de Bruin, A., & Westendorp, B. (2022) · Oncogene · doi:10.1038/s41388-022-02291-0 · Cited by 21
Mechanisms used by cancer cells to tolerate drug-induced replication stress
Segeren, H. A., & Westendorp, B. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215804 · Cited by 23
Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase
Wayne, J., Brooks, T., & Massey, A. J. (2016) · Oncotarget · doi:10.18632/oncotarget.13119 · Cited by 21
A mechanism for Rad53 to couple leading- and lagging-strand DNA synthesis under replication stress in budding yeast
Serra‐Cardona, A., Yu, C., Zhang, X., Hua, X., Yao, Y., Zhou, J., Gan, H., & Zhang, Z. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109334118 · Cited by 21
Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets
Sun, M., Ji, Y., Zhang, G., Li, Y., Dong, F., & Wu, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117147 · Cited by 23
A high-resolution, nanopore-based artificial intelligence assay for DNA replication stress in human cancer cells
Jones, M. V., Rai, S. K., Pfuderer, P. L., Bonfim‐Melo, A., Pagan, J. K., Clarke, P. R., Totañes, F. I. G., Merrick, C. J., McClelland, S. E., & Boemo, M. A. (2025) · Nature Communications · doi:10.1038/s41467-025-63168-w · Cited by 39
CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation
Liang, M., Zhao, T., Ma, L., & Guo, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.6168 · Cited by 20
Targeting the DNA-PK complex: Its rationale use in cancer and HIV-1 infection
Schwartz, C., Rohr, O., & Wallet, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.12.002 · Cited by 20
ATR activation is regulated by dimerization of ATR activating proteins
Thada, V., & Cortez, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100455 · Cited by 24
A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress
Egger, T., Bordignon, B., & Coquelle, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-09308-4 · Cited by 23
Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives
Kwok, M., Agathanggelou, A., Davies, N., & Stanković, T. (2021) · Cancers · doi:10.3390/cancers13184681 · Cited by 20
Inhibition of CHK 1 and WEE 1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
Restelli, V., Vagni, M., Arribas, A. J., Bertoni, F., Damia, G. L. M., & Carrassa, L. (2016) · British Journal of Haematology · doi:10.1111/bjh.14506 · Cited by 19
Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
Maresca, L., Stecca, B. A., & Carrassa, L. (2022) · Cells · doi:10.3390/cells11091466 · Cited by 17
Distinct cellular responses to replication stress leading to apoptosis or senescence
Lukášová, E., Řezáčová, M., Bačı́ková, A., Šebejová, L., Vávrová, J., & Kozubek, S. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12632 · Cited by 17
SLX4–XPF mediates DNA damage responses to replication stress induced by DNA–protein interactions
Ishimoto, R., Tsuzuki, Y., Matsumura, T., Kurashige, S., Enokitani, K., Narimatsu, K., Higa, M., Sugimoto, N., Yoshida, K., & Fujita, M. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202003148 · Cited by 17
The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response
Barone, G., Arora, A., Ganesh, A. N., Abdel-Fatah, T. M. A., Moseley, P. M., Ali, R., Chan, S. Y. T., Savva, C., Schiavone, K., Carmell, N., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25686 · Cited by 17
SAF-A promotes origin licensing and replication fork progression to ensure robust DNA replication
Connolly, C., Takahashi, S., Miura, H., Hiratani, I., Gilbert, N., Donaldson, A. D., & Hiraga, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.258991 · Cited by 16
Profilin-1 regulates DNA replication forks in a context-dependent fashion by interacting with SNF2H and BOD1L
Zhu, C., Iwase, M., Li, Z., Wang, F., Quinet, A., Vindigni, A., & Shao, J. (2022) · Nature Communications · doi:10.1038/s41467-022-34310-9 · Cited by 16
The CRL4DTL E3 ligase induces degradation of the DNA replication initiation factor TICRR/TRESLIN specifically during S phase
Wittig, K. A., Sansam, C. G., Noble, T. D., Goins, D., & Sansam, C. L. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab805 · Cited by 16
The Ataxia telangiectasia-mutated and Rad3-related protein kinase regulates cellular hydrogen sulfide concentrations
Chen, J., Shen, X., Pardue, S., Meram, A. T., Rajendran, S., Ghali, G. E., Kevil, C. G., & Shackelford, R. E. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.11.002 · Cited by 16
Exploiting DNA Replication Stress as a Therapeutic Strategy for Breast Cancer
Zhang, J., Chan, D. W., & Lin, S. (2022) · Biomedicines · doi:10.3390/biomedicines10112775 · Cited by 14
Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness
Oropeza, E., Şeker, S., Carrel, S., Mazumder, A., Lozano, D., Jimenez, A., VandenHeuvel, S. N., Noltensmeyer, D. A., Punturi, N. B., Lei, J. T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf2860 · Cited by 15
Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor
Chow, Z., Johnson, J., Chauhan, A., Jeong, J. C., Castle, J. T., Izumi, T., Weiss, H. L., Townsend, C. M., Schrader, J., Anthony, L. B., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216993 · Cited by 15
ATR Kinase Is a Crucial Player Mediating the DNA Damage Response in Trypanosoma brucei
Marín, P. M., Obonaga, R., Pavani, R., da Silva, M. S., de Araujo, C. B., Lima, A. A., Avila, C. C., Cestari, I. D. S., Machado, C. R., & Elias, M. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602956 · Cited by 15
ATR-CHK1 Axis Inhibitors in Gastric Cancer Treatment
Kciuk, M., Gruszka, R., Aleksandrowicz, M., Śliwińska, A., & Kontek, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167709 · Cited by 15
A DNA damage–induced phosphorylation circuit enhances Mec1 ATR Ddc2 ATRIP recruitment to Replication Protein A
Yates, L. A., Tannous, E., Morgan, R. M. L., Burgers, P., & Zhang, X. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300150120 · Cited by 13
Replisome dysfunction upon inducible TIMELESS degradation synergizes with ATR inhibition to trigger replication catastrophe
Patel, J. A., Zezelic, C., Rageul, J., Saldanha, J., Khan, A., & Kim, H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad363 · Cited by 15
ATR protects centromere identity by promoting DAXX association with PML nuclear bodies
Trier, I., Black, E. M., Joo, Y. K., & Kabeche, L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112495 · Cited by 14
Inhibition of MEK and ATR is effective in a B-cell acute lymphoblastic leukemia model driven by Mll-Af4 and activated Ras
Chu, S. H., Song, E. J., Chabon, J. R., Minehart, J. C., Matovina, C. N., Makofske, J. L., Frank, E. S., Ross, K. N., Koche, R. P., Feng, Z., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018021592 · Cited by 15
Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer
Gajek, A., Gralewska, P., Marczak, A., & Rogalska, A. (2021) · Cancers · doi:10.3390/cancers13112690 · Cited by 14
Inhibition of the ATR kinase enhances 5-FU sensitivity independently of nonhomologous end-joining and homologous recombination repair pathways
Ito, S. S., Nakagawa, Y., Matsubayashi, M., Sakaguchi, Y. M., Kobashigawa, S., Matsui, T. K., Nanaura, H., Nakanishi, M., Kitayoshi, F., Kikuchi, S., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013726 · Cited by 12
Ring finger protein 126 promotes breast cancer metastasis and serves as a potential target to improve the therapeutic sensitivity of ATR inhibitors
You, P., Yang, Y., Huang, R., Yang, H., Huang, Q., Ji, Y., Dai, J., Qiao, K., Tang, W., Xie, L., et al. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01586-0 · Cited by 13
Genome maintenance meets mechanobiology
Spegg, V., & Altmeyer, M. (2023) · Chromosoma · doi:10.1007/s00412-023-00807-5 · Cited by 14
A Survey of Essential Genome Stability Genes Reveals That Replication Stress Mitigation Is Critical for Peri-Implantation Embryogenesis
Kafer, G. R., & Cesare, A. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00416 · Cited by 12
Protective Mechanisms Against DNA Replication Stress in the Nervous System
Charlier, C. F., & Martins, R. A. P. (2020) · Genes · doi:10.3390/genes11070730 · Cited by 16

Authors: Buisson, R., Boisvert, J. L., Benes, C. H., & Zou, L.
Affiliations: Harvard University (US)
Corresponding author: Zou, Lee
ORCID: Buisson, Rémi
Benes, Cyril H.
Zou, Lee
Venue: Molecular Cell
Publisher: Elsevier BV
Published: 2015-09
Volume: 59
Issue: 6
Pages: 1011-1024
ISSN: 1097-2765 (ISSN-L)
DOI: 10.1016/j.molcel.2015.07.029
PMC: PMC4575890
OpenAlex: W1855851918
Cited by: 316
References: 72
Citations by year: 2026: 27 · 2025: 14 · 2024: 16 · 2023: 27 · 2022: 33 · 2021: 37 · 2020: 38 · 2019: 30 · 2018: 38 · 2017: 29 · 2016: 25 · 2015: 2
FWCI: 13.61
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 382 d)
Locations: Molecular Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: Wellcome Trust (102696)
National Institute of General Medical Sciences (R01GM076388, GM076388)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords: ATR, DNA-dependent protein kinase, Chk1, replication stress, S phase, DNA damage response, RRM2, replication origin firing, single-stranded DNA, replication catastrophe, cancer cell lines
MeSH terms: Checkpoint Kinase 1, DNA Damage, DNA Replication, DNA, Single-Stranded, Humans, Nuclear Proteins, Phosphorylation, Protein Kinases, Protein Processing, Post-Translational, Ribonucleoside Diphosphate Reductase, Stress, Physiological, S Phase, Replication Origin, Cell Line, Tumor, DNA-Activated Protein Kinase, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks